Investments	9 Months Ended
Sep. 30, 2024
Investments [Abstract]
Investments	Investments The Company holds several investments in and loans to non-consolidated entities which are included in Other assets in the condensed consolidated balance sheet. Equity Method Investments Equity method investments were $84.4 million and $83.1 million at September 30, 2024 and December 31, 2023, respectively. Non-marketable Equity Securities Investments in non-marketable equity securities were $43.9 million and $41.6 million at September 30, 2024 and December 31, 2023, respectively. No gains or losses were recorded on non-marketable equity securities for the three and nine months ended September 30, 2024, or the three months ended September 30, 2023. During the nine months ended September 30, 2023, the Company recognized impairment charges of $1.7 million on certain investments, which are included in Miscellaneous, net in the condensed consolidated statements of income.

Investments

9 Months Ended

Sep. 30, 2024

The Company holds several investments in and loans to non-consolidated entities which are included in Other assets in the condensed consolidated balance sheet.

Equity Method Investments

Equity method investments were $84.4 million and $83.1 million at September 30, 2024 and December 31, 2023, respectively.

Non-marketable Equity Securities

Investments in non-marketable equity securities were $43.9 million and $41.6 million at September 30, 2024 and December 31, 2023, respectively. No gains or losses were recorded on non-marketable equity securities for the three and nine months ended September 30, 2024, or the three months ended September 30, 2023. During the nine months ended September 30, 2023, the Company recognized impairment charges of $1.7 million on certain investments, which are included in Miscellaneous, net in the condensed consolidated statements of income.